Premium
Bisphosphonates treatment and orthodontic considerations
Author(s) -
Ghoneima AA,
Allam ES,
Zunt SL,
Windsor LJ
Publication year - 2010
Publication title -
orthodontics and craniofacial research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.664
H-Index - 55
eISSN - 1601-6343
pISSN - 1601-6335
DOI - 10.1111/j.1601-6343.2009.01472.x
Subject(s) - medicine , osteoporosis , dentistry , intensive care medicine , regimen , surgery
To cite this article:
Ghoneima AA, Allam ES, Zunt SL, Windsor LJ:
Bisphosphonates treatment and orthodontic considerations
Orthod Craniofac Res 2010; 13 :1–10 Abstract Authors – Ghoneima AA, Allam ES, Zunt SL, Windsor LJ Currently, the use of oral and systemic forms of bisphosphonates is increasing dramatically in a large group of patients either in the form of anti‐osteoporosis medications or as a part of a chemotherapeutic regimen for several malignant diseases. As adult orthodontic treatment has become more widely accepted in most orthodontic practices, orthodontists must be aware of the risks, benefits, and effects of bisphosphonates use on the patient’s general health status, as well as on their orthodontic treatment outcomes. This review aims to discuss the use of bisphosphonates, the complications associated with their use, and their impact on orthodontic treatment.